NewcelX Ltd. (NCEL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NCEL Profit Margin, ROE & Profitability Analysis
NCEL vs Healthcare Sector: How NewcelX Ltd. Compares
How NewcelX Ltd. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NewcelX Ltd. Stock Overvalued? NCEL Valuation Analysis 2026
Based on fundamental analysis, NewcelX Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NewcelX Ltd. Balance Sheet: NCEL Debt, Cash & Liquidity
NCEL Revenue Growth, EPS Growth & YoY Performance
NCEL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for NewcelX Ltd. (CIK: 0001783036)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NCEL
What is the AI rating for NCEL?
NewcelX Ltd. (NCEL) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NCEL's key strengths?
Claude: Analysis in progress.
What are the risks of investing in NCEL?
Claude: Analysis in progress.
What is NCEL's revenue and growth?
NewcelX Ltd. reported revenue of N/A.
Does NCEL pay dividends?
NewcelX Ltd. does not currently pay dividends.
Where can I find NCEL SEC filings?
Official SEC filings for NewcelX Ltd. (CIK: 0001783036) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NCEL's EPS?
NewcelX Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is NCEL's fundamental grade?
Based on our AI fundamental analysis in July 2026, NewcelX Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is NCEL stock overvalued or undervalued?
Valuation metrics for NCEL: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is NCEL's AI grade for 2026?
Our dual AI analysis gives NewcelX Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NCEL's free cash flow?
NewcelX Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does NCEL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).